Investors purchased shares of AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) on weakness during trading on Friday. $41.67 million flowed into the stock on the tick-up and $20.69 million flowed out of the stock on the tick-down, for a money net flow of $20.98 million into the stock. Of all companies tracked, AmerisourceBergen Corporation (Holding Co) had the 24th highest net in-flow for the day. AmerisourceBergen Corporation (Holding Co) traded down ($0.06) for the day and closed at $82.50

Several equities research analysts have issued reports on the stock. ValuEngine lowered shares of AmerisourceBergen Corporation (Holding Co) from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Jefferies Group LLC set a $95.00 price target on shares of AmerisourceBergen Corporation (Holding Co) and gave the company a “hold” rating in a research note on Tuesday, August 29th. Leerink Swann set a $90.00 price target on shares of AmerisourceBergen Corporation (Holding Co) and gave the company a “buy” rating in a research note on Monday, August 7th. BidaskClub lowered shares of AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Finally, TheStreet lowered shares of AmerisourceBergen Corporation (Holding Co) from a “b” rating to a “c+” rating in a research note on Thursday, August 3rd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $93.14.

The stock has a market cap of $18.08 billion, a P/E ratio of 21.50 and a beta of 0.95. The firm has a 50-day moving average of $83.49 and a 200-day moving average of $88.02.

AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last announced its earnings results on Thursday, August 3rd. The company reported $1.43 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.37 by $0.06. The company had revenue of $38.71 billion during the quarter, compared to the consensus estimate of $39.13 billion. AmerisourceBergen Corporation (Holding Co) had a net margin of 0.56% and a return on equity of 56.07%. The firm’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.37 earnings per share. Equities research analysts predict that AmerisourceBergen Corporation will post $5.88 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 5th. Stockholders of record on Monday, August 21st were issued a $0.365 dividend. The ex-dividend date was Thursday, August 17th. This represents a $1.46 annualized dividend and a dividend yield of 1.77%. AmerisourceBergen Corporation (Holding Co)’s dividend payout ratio is currently 38.02%.

In other news, Chairman Steven H. Collis sold 15,000 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $94.76, for a total value of $1,421,400.00. Following the completion of the sale, the chairman now owns 253,876 shares in the company, valued at $24,057,289.76. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Peyton R. Howell sold 20,000 shares of the stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $80.00, for a total transaction of $1,600,000.00. Following the completion of the sale, the insider now owns 57,135 shares of the company’s stock, valued at approximately $4,570,800. The disclosure for this sale can be found here. In the last quarter, insiders sold 51,273 shares of company stock valued at $4,323,237. 27.40% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in ABC. Parallel Advisors LLC raised its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 3.2% in the second quarter. Parallel Advisors LLC now owns 1,109 shares of the company’s stock valued at $104,000 after purchasing an additional 34 shares during the last quarter. Point72 Asia Hong Kong Ltd purchased a new stake in shares of AmerisourceBergen Corporation (Holding Co) in the first quarter valued at about $105,000. American Beacon Advisors Inc. purchased a new stake in shares of AmerisourceBergen Corporation (Holding Co) in the first quarter valued at about $108,000. SRS Capital Advisors Inc. raised its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 0.3% in the first quarter. SRS Capital Advisors Inc. now owns 1,235 shares of the company’s stock valued at $109,000 after purchasing an additional 4 shares during the last quarter. Finally, Sun Life Financial INC raised its holdings in shares of AmerisourceBergen Corporation (Holding Co) by 15,000.0% in the second quarter. Sun Life Financial INC now owns 1,208 shares of the company’s stock valued at $114,000 after purchasing an additional 1,200 shares during the last quarter. Institutional investors own 67.67% of the company’s stock.

WARNING: “Traders Buy AmerisourceBergen Corporation (Holding Co) (ABC) on Weakness” was originally posted by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright law. The correct version of this report can be read at https://www.dailypolitical.com/2017/09/08/traders-buy-amerisourcebergen-corporation-holding-co-abc-on-weakness.html.

About AmerisourceBergen Corporation (Holding Co)

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.